Grown Rogue International (GRUSF) Operating Income Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -150.77% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -10.00% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.93% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -9.25% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -97.30% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 4.05% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 12.73% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 93.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.96% |
| Mar 31, 2026 | 114.05% |
| Dec 31, 2025 | 2,392,297,594.27% |
| Sep 30, 2025 | 51,166,335.52% |
| Jun 30, 2025 | -935,860,437,431,563.88% |
| Mar 31, 2025 | -176.52% |
| Dec 31, 2024 | -85.93% |
| Jan 31, 2023 | 32.92% |
| Jan 31, 2022 | -50.70% |
| Oct 31, 2021 | 1,576.72% |
| Jul 31, 2021 | 202.81% |
| Apr 30, 2021 | -4.26% |
| Jan 31, 2021 | 652.70% |
| Oct 31, 2020 | 76.35% |
| Jul 31, 2020 | 20.11% |
| Apr 30, 2020 | 63.99% |
| Jan 31, 2020 | 96.17% |
| Oct 31, 2019 | 73.23% |
| Jul 31, 2019 | -118.06% |
| Apr 30, 2019 | -97.02% |